Used as an intermediate in the synthesis of nitroimidazole-based pharmaceuticals, particularly in the development of antiprotozoal and antimicrobial agents. Its structure supports the formation of biologically active compounds that target anaerobic bacteria and certain parasites. Commonly employed in research settings for designing new derivatives with enhanced efficacy and reduced toxicity. Also utilized in the preparation of labeled compounds for metabolic studies.